Daily Hong Kong Stock Market News Briefing (February 6, Thursday)

USHK News
2025.02.06 01:07

  1. HSBC HOLDINGS (00005.HK): The company repurchased 2.1976 million shares on February 4, with a maximum repurchase price of HKD 80.45 per share and a minimum price of HKD 79.6. The total amount paid was HKD 176.13 million.

  2. HENLIUS (02696.HK): The European Commission approved the use of Suliqua injection in combination with chemotherapy as a first-line treatment for adult patients with extensive-stage small cell lung cancer.

  3. Brain Hole Technology (02203.HK): On February 4, the company further purchased a total of 8,400 shares of Affirm in the open market for a total cost of approximately USD 500,000 (excluding transaction costs).

  4. JD.com (09618.HK) is reported to be in talks to acquire the German electronics retailer Ceconomy again.

  5. Hema Medical (03309.HK): Issued a profit warning, expecting net profit in 2024 to decrease to approximately HKD 50 million to 60 million year-on-year.

  6. Intercontinental Aerospace Technology (01725.HK): Aspace and IAF signed a joint hosting agreement for the exhibition of 100 satellites produced by Aspace in multiple countries

Source: USHK News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.